| __timestamp | Bristol-Myers Squibb Company | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 4320000 |
| Thursday, January 1, 2015 | 16560000000 | 2538000 |
| Friday, January 1, 2016 | 19427000000 | 3337000 |
| Sunday, January 1, 2017 | 20776000000 | 4003000 |
| Monday, January 1, 2018 | 22561000000 | 8386000 |
| Tuesday, January 1, 2019 | 26145000000 | 4461000 |
| Wednesday, January 1, 2020 | 42518000000 | 1050000 |
| Friday, January 1, 2021 | 46385000000 | 2963000 |
| Saturday, January 1, 2022 | 46159000000 | 1772000 |
| Sunday, January 1, 2023 | 45006000000 | 314000 |
| Monday, January 1, 2024 | 48300000000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical industry, revenue growth is a key indicator of a company's success. Over the past decade, Bristol-Myers Squibb Company has demonstrated a robust financial trajectory, with its revenue soaring by approximately 183% from 2014 to 2023. This growth underscores its strategic prowess and market dominance. In stark contrast, Viridian Therapeutics, Inc., a smaller player in the field, has faced a more turbulent journey. Despite a peak in 2018, its revenue has seen a significant decline, dropping by nearly 93% by 2023. This comparison highlights the challenges smaller biotech firms face in scaling operations and achieving consistent growth. As the industry continues to innovate, the financial narratives of these companies offer valuable insights into the dynamics of pharmaceutical success.
Novartis AG or Bristol-Myers Squibb Company: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Corcept Therapeutics Incorporated
Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Bristol-Myers Squibb Company vs MorphoSys AG
Who Generates More Revenue? Bristol-Myers Squibb Company or Merus N.V.
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.
Vericel Corporation and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Viridian Therapeutics, Inc.
Revenue Insights: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. Performance Compared